Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to... see more

TSXV:SBM - Post Discussion

Sirona Biochem Corp > Retinol market size
View:
Post by Turtle4 on Dec 12, 2023 7:30am

Retinol market size

https://www.grandviewresearch.com/industry-analysis/retinol-market-report

The global retinol market size was valued at USD 1.33 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 3.8% from 2023 to 2030. this is now only the ingredient without revenue share.

Cosmetics make up around 50% of the retinol market. 

Now you can think, calculate and dream up a possible market share for Glycoprotemim.

Have fun and buy shares of this 20 mio. ca$ market cap company.
Comment by 24minus7 on Dec 12, 2023 7:42am
Let's include Botox with an opinion by Bard: Sirona Biochem's GlycoProteMim™ is a novel anti-aging molecule that has the potential to be a viable alternative to Botox. Both GlycoProteMim™ and Botox are used to address the signs of aging, such as wrinkles and fine lines. However, they work in different ways.   Botulinum toxin, the active ingredient in Botox, is a neurotoxin that ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities